BioNTech is a German biotechnology company that focuses on the development of immunotherapies for cancer and other serious diseases. Founded in 2008, the company is known for its mRNA technology, which plays a significant role in the production of vaccines. BioNTech gained global prominence for its collaboration with Pfizer to develop one of the first COVID-19 vaccines authorized for emergency use, leveraging messenger RNA (mRNA) technology to prompt an immune response against the virus. The term “BioNTech” reflects the company’s focus on biological technology and innovation in the biotech space.
BioNTech is shifting focus from COVID-19 vaccines to pioneering mRNA-based cancer therapies amid falling vaccine profits. Projected revenues are decreasing, from 3.82 billion euros in 2023 to 1.7 to 2.2…